76397-9

LOINC Code


LOINC code76397-9
name
descriptionPatients are allocated into two risk groups based on lymph node involvement; the risk group for node-negative patients, and the risk group for node-positive (1-3) patients. This term was created for, but not limited in use to, the Prosigna Breast Cancer Prognostic Gene Signature assay, which is based on the reported 50-gene classifier algorithm originally named PAM50.
statusACTIVE

Fully-Specified Name

componentLymph node involvement
propertyFind  =  Finding
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemLymph node
scaleOrd  =  Ordinal:  Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive.
method

Additional Names

short nameFinding; Findings; Ln; LN involved; Ordinal; Pathology; Point in time; QL; Qual; Qualitative; Random; Screen

Basic Attributes

classPATH
type1  Laboratory
order vs. observationLN involved LN

Member of these Panels

76546-1

History/Usage

first released
last updated2.73
last change typeMIN  - change to field other than name

Related Names



Copyright © 2026 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2026, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee - AI-powered coding assistant Would you like Aimee - AI
to help you with this?